Market Cap | ₹26,386Cr |
ROE | 1.12% |
P/E Ratio(TTM) | 268.24 |
EPS(TTM) | 0.74 |
P/B Ratio | 3.25 |
Dividend Yield | 0.07% |
Industry P/E | 34.29 |
Book Value | 61.17 |
Debt to Equity | 0.60 |
Face Value | 10 |
Parent Organisation | Piramal Pharma |
NSE Symbol | PPLPHARMA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 37.80 | ||
Cipla | NA (0.00%) | 22.70 | ||
Dr Reddy's Laboratories | NA (0.00%) | 18.34 | ||
Mankind Pharma | NA (0.00%) | 53.40 |